Resultado final
The public project website will serve several purposes, including a) being the central go-to-point for consortium members to look up contact information of other partners and to log into the confidential intranet, b) providing a concise overview of the project’s goals, its work packages, and the scientific background to the general public, and c) continuously informing patients and the general public on project-related events, publications, downloads and newsworthy developments. Patient-relevant information will be made available in several common EU languages.
Project brochure (for patients, laymen and scientists) and professional templatesThe project brochure will be a handy flyer or folder that summarises the project’s vision, why it matters, its key objectives, the partner institutions, basic facts (start date, duration, number of countries, funding amount etc.) for transparency, the website URL, and contact information of the scientific coordinator and the project Manager.
VideoA video will be produced for the general public and patients (target audience) explaining the problem of chronic pain and the secondary problems, the lack of adequate treatment for many chronic pain patients, as well as the key goals of the QSPainRelief project in form of animated filmed interviews with the coordinator and WP leaders.
Jointly with one of the relevant patient organisations, the first layman event will take place within the first 6 months, including a Q & A session at a convenient location (most likely connected to an SC Meeting) where partnering clinicians and researchers explain the scope of the project and answer questions of patients and the general public.
Document identifying the selected drugs out of the list of EU approved medications their simulated CNS drug distribution and ontarget functional concentration derived from clinical studies
Publicaciones
Autores:
Adrián Ricarte, James A. R. Dalton, Jesús Giraldo
Publicado en:
Journal of Chemical Information and Modeling, Edición 61/3, 2021, Página(s) 1251-1274, ISSN 1549-9596
Editor:
American Chemical Society
DOI:
10.1021/acs.jcim.0c00890
Autores:
Pedro Renault, Jesús Giraldo
Publicado en:
International Journal of Molecular Sciences, Edición 22/1, 2021, Página(s) 187, ISSN 1422-0067
Editor:
Multidisciplinary Digital Publishing Institute (MDPI)
DOI:
10.3390/ijms22010187
Autores:
Oscar Díaz, Pedro Renault, and Jesús Giraldo
Publicado en:
ACS Omega, Edición 7, 42, 2022, Página(s) 37873–37884, ISSN 2470-1343
Editor:
American Chemical Society (ACS) Publications
DOI:
10.1021/acsomega.2c04980
Autores:
Óscar Díaz, Victor Martín, Pedro Renault, David Romero, Antoni Guillamon, Jesús Giraldo
Publicado en:
Drug Discovery Today, Edición Volume 28, Edición 2, 2023, ISSN 1359-6446
Editor:
Elsevier BV
DOI:
10.1016/j.drudis.2022.103441
Autores:
Agustín Bruzzese, James A. R. Dalton, Jesús Giraldo
Publicado en:
Scientific Reports, Edición 10/1, 2020, ISSN 2045-2322
Editor:
Nature Publishing Group
DOI:
10.1038/s41598-020-77072-4
Autores:
Bertayli M,Hijma H, Bakker W, Groeneveld GJ, Elassaiss-Schaap S
Publicado en:
PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe., 2022
Editor:
Population Approach Group in Europe
Buscando datos de OpenAIRE...
Se ha producido un error en la búsqueda de datos de OpenAIRE
No hay resultados disponibles